Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
STX-001 by Strand Therapeutics for Melanoma: Likelihood of Approval
STX-001 is under clinical development by Strand Therapeutics and currently in Phase II for Melanoma. According to GlobalData, Phase II...
STX-001 by Strand Therapeutics for Solid Tumor: Likelihood of Approval
STX-001 is under clinical development by Strand Therapeutics and currently in Phase II for Solid Tumor. According to GlobalData, Phase...
STX-001 by Strand Therapeutics for Triple-Negative Breast Cancer (TNBC): Likelihood of Approval
STX-001 is under clinical development by Strand Therapeutics and currently in Phase II for Triple-Negative Breast Cancer (TNBC). According to...